Revolution Medicines Balance Sheet Health
Financial Health criteria checks 6/6
Revolution Medicines has a total shareholder equity of $1.6B and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.8B and $196.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.55b |
| Equity | US$1.57b |
| Total liabilities | US$196.70m |
| Total assets | US$1.76b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 42Z's short term assets ($1.6B) exceed its short term liabilities ($110.9M).
Long Term Liabilities: 42Z's short term assets ($1.6B) exceed its long term liabilities ($85.8M).
Debt to Equity History and Analysis
Debt Level: 42Z is debt free.
Reducing Debt: 42Z has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 42Z has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 42Z has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 42.7% each year.